FGF23 effects on the heart—levels, time, source, and context matter

Christian Faul

Research output: Contribution to journalComment/debatepeer-review

15 Scopus citations

Abstract

Fibroblast growth factor 23 (FGF23) has appeared as a hormone that is massively elevated in patients with chronic kidney disease. Whether FGF23 is a risk factor that associates with cardiac pathologies and cardiovascular mortality, as suggested by a variety of clinical studies, or additionally acts as a causative factor that induces cardiac injury, as more recently indicated by cell culture and animal studies, is under debate and the center of many ongoing experimental studies.

Original languageEnglish (US)
Pages (from-to)7-11
Number of pages5
JournalKidney international
Volume94
Issue number1
DOIs
StatePublished - Jul 2018

ASJC Scopus subject areas

  • Nephrology

Fingerprint Dive into the research topics of 'FGF23 effects on the heart—levels, time, source, and context matter'. Together they form a unique fingerprint.

Cite this